Squadron Master Fund LP 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 11:36 am Purchase | 2025-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Squadron Master Fund LP | 2,329,749 9.900% | 76,819 (+3.41%) | Filing |
| 2025-12-05 4:10 pm Purchase | 2025-11-28 | 13G | Pasithea Therapeutics Corp. KTTA | Squadron Master Fund LP | 2,252,930 9.900% | 2,252,930 (New Position) | Filing |